Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G
Anaptysbio Inc
Nov 21, 2025
Anaptys Announces $100 Million Stock Repurchase Plan
Jan 16, 2026
[Form 4] ANAPTYSBIO, INC Insider Trading Activity
Jan 6, 2026
[144] ANAPTYSBIO, INC SEC Filing
1.40B
26.01M
5.82%
124.31%
34.67%
Biotechnology
Pharmaceutical Preparations
United States
SAN DIEGO